FindTrial
Sign In

During 0peration thoracic nerve block given with 0.25% Levo-bupivacaine vs 0.25% Levo-bupivacaine plus dexmedetomidine for post-operative pain relief after breast cancer surgery – Randomized, Comparative and Controlled Study

Intra-operative thoracic interfascial plane block with 0.25% Levo-bupivacaine vs 0.25% Levo-bupivacaine plus dexmedetomidine for post-operative analgesia after MRM – Randomized, Comparative and Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/030004
Enrollment
60
Registered
2020-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

Intervention1: intra operative thoracic interfascial plane block: 10 ml of 0.25% levo bupivacaine plus 2 ml of normal saline between pectoralis pectoralis major and pectoralis minor and between pector

Sponsors

IGIMS Patna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: posted for modified radical mastectomy

Exclusion criteria

Exclusion criteria: 1. Patient refusal 2. Local anaesthetic allergy 3. Bleeding diathesis 4. Locally advanced breast malignancy with infiltration of chest wall 5. Deranged liver function

Design outcomes

Primary

MeasureTime frame
– Duration of post-operative analgesiaTimepoint: – Duration of post-operative analgesia using NRS scale just after shifting the patient in PACU, then at the interval of 2 hour, 4 hour, 8 hour, 12 hour and 24 hour—

Secondary

MeasureTime frame
any side effects and total consumption of opioids in both groups.Timepoint: 24 hours—

Countries

India

Contacts

Public ContactRaja Avinash

IGIMS,Patna

raja.avinash007@gmail.com9905012125

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026